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ORIGINAL ARTICLENo Causal Association between
25-Hydroxyvitamin D and Features of Skin
Aging: Evidence from a Bidirectional
Mendelian Randomization Study
Raymond Noordam1,9, Merel A. Hamer2,9, Luba M. Pardo2, Tamara van der Nat1,
Jessica C. Kiefte-de Jong3,4, Manfred Kayser5, P Eline Slagboom6, Andre´ Uitterlinden3,7,
M. Carola Zillikens7, Marian Beekman6, Tamar Nijsten2, Diana van Heemst1 and David A. Gunn8Data from in vitro experiments suggest that vitamin D reduces the rate of skin aging, whereas population studies
suggest the opposite, most likely due to confounding by UV exposure. We investigated whether there are causal
associations between 25-hydroxyvitamin D concentrations and features of skin aging in a bidirectional Mendelian
randomization study. In the Rotterdam Study (N¼ 3,831; 58.2%women, median age 66.5 years) and Leiden Longevity
Study (N¼ 661; 50.5%women,median age 63.1 years), facial skin aging features (perceived age, wrinkling, pigmented
spots) were assessed eithermanually or digitally. Associations between 25-hydroxyvitamin D and skin aging features
were tested by multivariable linear regression. Mendelian randomization analyses were performed using single
nucleotidepolymorphisms identified fromprevious genome-wide association studies. Aftermeta-analysis of the two
cohorts, we observed that higher serum 25-hydroxyvitamin Dwas associated with a higher perceived age (P-value¼
3.6  10e7), more skin wrinkling (P-value ¼ 2.6  10e16), but not with more pigmented spots (P-value ¼ 0.30). In
contrast, a genetically determined 25-hydroxyvitaminD concentrationwas not associatedwith any skin aging feature
(P-values > 0.05). Furthermore, a genetically determined higher degree of pigmented spots was not associated with
higher25-hydroxyvitaminD(P-values> 0.05).Our studydidnot indicate that associationsbetween25-hydroxyvitamin
D and features of skin aging are causal.
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A higher perceived age—estimated age based on facial appear-
ance—is associated with an increased risk of morbidity and
mortality (Christensen et al., 2009), making it a useful marker in
aging research. In addition to well-described extrinsic factors,
such as smoking and UV exposure (Christensen et al., 2009;
Griffiths, 1992; Rexbye et al., 2006), a higher perceived age
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that high serum concentrations of glucose and cortisol were
associated with a higher perceived age (Noordam et al., 2012,
2013b), whereas a high concentration of insulin-like growth
factor-1 was associated with a lower perceived age mainly
through skinwrinkling (Noordamet al., 2013a; vanDrielen et al.,
2015b). Besides skin wrinkling, facial pigmented spots are also
an important component of skin aging.
Although sun exposure contributes to premature skin aging
(Christensen et al., 2009; Griffiths, 1992), it is essential for
vitamin D synthesis in the skin (Holick, 2007) and vitamin D
is essential for musculoskeletal health. Moreover, in clinical
practice, low serum concentrations of 25-hydroxyvitamin D
or vitamin D deficiency is a broadly accepted marker for
general health status, and has been associated with multiple
extraskeletal age-related diseases (e.g., type 2 diabetes mel-
litus and cardiovascular disease), and mortality (Andrukhova
et al., 2014; Chowdhury et al., 2014; Lee et al., 2011;
Mathieu et al., 2005; Pilz et al., 2009, 2011).
Different in vitro studies have shown that physiological con-
centrations of 1,25-hydroxyvitamin D, the active vitamin D
metabolite, protect the skin against factors that promote skin
aging, including cellular damage induced by UVB irradiation.
Vitamin D has been demonstrated to influence keratinocyte
proliferation (Gniadecki, 1996) and differentiation (Manggau
et al., 2001) with the response dependent on vitamin D con-
centrations and culture conditions (Bollag et al., 1995;
Gniadecki, 1996). Although the bioavailable levels of vitaminestigative Dermatology. www.jidonline.org 2291
Table 1. Characteristics of the study population
Rotterdam Study (N [ 3,831) Leiden Longevity Study (N [ 661)
General
Chronological age (y), median (IQR) 66.5 (61.0, 71.5) 63.1 (58.9, 67.5)
Females, N (%) 2,229 (58.2) 334 (50.4)
Body mass index (kg/m2), mean (SD) 27.6 (4.4) 26.6 (4.0)
Current smoking, N (%) 707 (18.5) 91 (13.8)
Skin aging features
Perceived age (y), mean (SD) 65.9 (7.6)1 59.4 (7.6)
Degree of skin wrinkling, median (IQR)2 3.9 (2.5, 6.0) 4.5 (3.5, 5.5)
Degree of pigmented spots, median (IQR)2 1.3 (0.9, 2.1)3 4.5 (3.5, 5.0)
Serum measurements
25-Hydroxyvitamin D (nmol/l), median (IQR) 61.0 (42.7, 82.3) 68.3 (54.0, 139.2)
Serum taken in winter season, N (%) 930 (24.3) 160 (24.2)
Serum taken in spring season, N (%) 1,107 (28.9) 214 (32.4)
Serum taken in summer season, N (%) 863 (22.5) 135 (20.4)
Serum taken in autumn season, N (%) 850 (22.2) 152 (23.0)
Abbreviations: IQR, interquartile range; N, number of participants; SD, standard deviation.
1Assessed in 2,679 individuals.
2For the Rotterdam Study, measured digitally as area (wrinkles or pigmented spots) as a percentage of the total facial area. For the Leiden Longevity Study,
wrinkle score and pigmented spots were measured manually by two expert dermatologists using a photonumeric scale ranging from 1 to 9.
3Assessed in 2,843 individuals.
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2292D in human skin are unknown, a higher serum concentration of
25-hydroxyvitamin D was associated with a higher number of
facial pigmented spots in the LeidenLongevity Study (vanDrielen
et al., 2015a). However, the nature of these studies is observa-
tional, and causality cannot be ascertained due to influences of,
for example, residual confounding by sunlight.
Causality can be inferred between a certain exposure and
outcome using Mendelian randomization studies (Lawlor
et al., 2008; Smith and Ebrahim, 2003). With such ana-
lyses, genetic polymorphisms that are strongly related to the
exposure are investigated in relation to the outcome, in the
absence of confounding. Therefore, we aimed to investigate
whether associations between serum 25-hydroxyvitamin D
and features of skin aging are causal using a bidirectional
Mendelian randomization study.
RESULTS
Characteristics of the study populations
A maximum of 3,831 participants from the Rotterdam Study
(median [interquartile range] age: 66.5 [61.0, 71.5] years)
and 661 participants from the Leiden Longevity Study (me-
dian [interquartile range] age: 63.1 [58.9, 67.5] years) were
included in the present study (Table 1). Compared with par-
ticipants from the Leiden Longevity Study, participants from
the Rotterdam Study were more frequently women (58.2%
vs. 50.4%), smokers (18.5% vs. 13.8%), and had a lower 25-
hydroxyvitamin D concentration (median: 61.0 nmol/l vs.
68.3 nmol/l). Also, in line with the higher mean chronolog-
ical age, participants from the Rotterdam Study had a higher
mean perceived age (mean: 65.9 years vs. 59.4 years).
Observational associations between a 25-hydroxyvitamin D
concentration and skin aging features
After meta-analyzing the results of the Rotterdam Study and the
Leiden Longevity Study (Table 2), a higher 25-hydroxyvitamin
D concentration was associated with a higher perceived age
(b ¼ 0.149 standard deviation [SD] per one ln[25-Journal of Investigative Dermatology (2017), Volume 137hydroxyvitamin D]; standard error [SE] ¼ 0.029; P-value ¼
3.58  10e7). However, this association disappeared after
additional adjustment for the degree of skin wrinkling (b ¼
0.020 SD per one ln[25-hydroxyvitamin D]; SE ¼ 0.022; P-
value ¼ 0.36). In line with this, a higher 25-hydroxyvitamin D
concentration was associated with a higher degree of skin
wrinkling (b ¼ 0.250 SD per one ln[25-hydroxyvitamin D];
SE ¼ 0.030; P-value ¼ 2.61  10e16). In contrast, a higher 25-
hydroxyvitamin D was only associated with a higher degree of
pigmented spots in the Leiden Longevity Study, and not in the
Rotterdam Study. After meta-analysis, a higher 25-
hydroxyvitamin D was not associated with a higher degree
of pigmented spots (b ¼ e0.033 SD per one ln[25-
hydroxyvitamin D]; SE ¼ 0.031; P-value ¼ 0.30). These re-
sults were similar when we additionally adjusted for UV
exposure, physical activity, and dietary vitamin D and any
vitamin D supplementation in the Rotterdam Study
(Supplementary Table S1 online), despite that we observed
strong associations between these factors and the 25-
hydroxyvitamin D level (Supplementary Table S2 online).
Mendelian randomization analyses between a 25-
hydroxyvitamin D concentration and skin aging features
We calculated, per participant, a weighted genetic score for a
25-hydroxyvitamin D concentration based on the single
nucleotide polymorphisms that were identified in a genome-
wide association study on a 25-hydroxyvitamin D concen-
tration (notably, rs2282679 [GC], rs3829251 [NADSYN1],
and rs2060793 [CYP2R1]; Ahn et al., 2010). On the basis of
the observational effect estimates, we had an 82% and 84%
power to detect significant (a ¼ 0.05) associations between
the 25-hydroxyvitamin D genetic risk score (GRS) and
perceived age and degree of skin wrinkling, respectively.
After meta-analysis, all three selected 25-hydroxyvitamin
D genotypes were associated with a 25-hydroxyvitamin D
concentration (Supplementary Table S3 online). In line with
Table 2. Association between serum 25-hydroxyvitamin D and features of skin aging
Rotterdam Study (N [ 3,831) Leiden Longevity Study (N [ 661) Meta-analysis
b (SE) P-value b (SE) P-value b (SE) P-value
Perceived age 0.128 (0.030)2 1.77  10e5 0.516 (0.127) 5.36  10e5 0.149 (0.029) 3.58  10e7
Perceived age, adjusted1 0.006 (0.023)2 7.82  10e1 0.225 (0.087) 9.84  10e3 0.020 (0.022) 3.61  10e1
Degree of skin wrinkling 0.241 (0.031) 2.17  10e14 0.507 (0.169) 2.73  10e3 0.250 (0.030) 2.61  10e16
Degree of pigmented spots e0.050 (0.032)3 1.16  10e1 0.571 (0.189) 2.63  10e3 e0.033 (0.031) 3.00  10e1
Effect estimates presented as the increase in standardized outcome per one ln-transformed unit increase in 25-hydroxyvitamin D serum concentration.
Abbreviation: SE, standard error.
1Analyses additionally adjusted for the degree of facial skin wrinkling. Effect estimates of the meta-analysis obtained using fixed-effect models.
2Analysis based on 2,679 individuals from the Rotterdam Study.
3Analysis based on 2,843 individuals from the Rotterdam Study. Analyses adjusted for chronological age, sex, season, current smoking status, and body mass
index. The results of the digitally measured wrinkles and pigmented spots in the Rotterdam Study were additionally adjusted for technical variables.
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25-hydroxyvitamin D concentration was associated with a
higher 25-hydroxyvitamin D concentration in our study
populations and meta-analysis (b ¼ 0.24 units ln[25-
hydroxyvitamin D] increase per one unit increase in ge-
netic score; SE ¼ 0.01; P-value ¼ 2.23  10e64).
After meta-analyzing the observed estimates of the
Rotterdam Study and the Leiden Longevity Study (Table 3),
a higher genetically determined 25-hydroxyvitamin D
concentration was not associated with (i) a higher
perceived age (b ¼ 0.030 SD per one genetically deter-
mined ln[25-hydroxyvitamin D]; SE ¼ 0.023; P-value ¼
0.18); (ii) a higher perceived age additionally adjusted
for skin wrinkling (b ¼ 0.017 SD per one genetically
determined ln[25-hydroxyvitamin D]; SE ¼ 0.016;
P-value ¼ 0.28); (iii) a higher degree of skin wrinkling
(b ¼ 0.000 SD per one genetically determined ln
[25-hydroxyvitamin D]; SE ¼ 0.028; P-value ¼ 1.00); (iv) a
higher degree of pigmented spots (b ¼ 0.055 SD per one
genetically determined ln[25-hydroxyvitamin D];
SE ¼ 0.030; P-value ¼ 0.07).
Mendelian randomization analyses between pigmented
spots and a 25-hydroxyivitamin D concentration
We found no evidence after meta-analyzing the results of the
Rotterdam Study and Leiden Longevity Study that any of the
genotypes for pigmented spots or perceived age (MC1R gene
only) or the genetic risk score for pigmented spots was
associated with a higher 25-hydroxyvitamin D concentration
(Table 4; e.g., b ¼ 0.146 ln[25-hydroxyvitamin D in nmol/l]
per one unit increases in pigmented spots GRS; SE ¼ 0.089;
P-value ¼ 0.10).
DISCUSSION
We found evidence that a higher serum 25-hydroxyvitamin D
concentration was associated with a higher perceived age
and a higher degree of skin wrinkling. However, we found no
evidence that a higher genetically determined 25-
hydroxyvitamin D was associated with any of the studied
skin aging features, nor was there evidence that a higher
genetically determined degree of pigmented spots was asso-
ciated with a higher 25-hydroxyvitamin D concentration.
These results suggest that the association between 25-
hydroxyvitamin D and skin aging features is not likely causal.In several observational studies, a low 25-hydroxyvitaminD
(Andrukhova et al., 2014; Lee et al., 2011; Mathieu et al.,
2005; Pilz et al., 2009, 2011) and a higher perceived age
(Christensen et al., 2009) are associated with an increased risk
of morbidity and mortality (Chowdhury et al., 2014). There-
fore, a low 25-hydroxyvitaminDmight associate with a higher
perceived age. However, participants with high 25-
hydroxyvitamin D concentrations likely have a higher fre-
quency of outdoor activities (e.g., physical activity, sun bath-
ing), better dietary quality, and lower fat mass (Vitezova et al.,
2017). As UVB exposure by sunlight is a predominant factor of
25-hydroxyvitamin D (Sallander et al., 2013) production and
contributes to skin aging, a higher 25-hydroxyvitamin D con-
centration might be associated with a higher perceived age.
Indeed, a higher 25-hydroxyvitamin D concentration was
associated with a higher perceived age in our study pop-
ulations. However, the attenuation of this association by the
adjustment for skin wrinkling suggests that 25-hydroxyvitamin
D only associates with certain aspects of skin aging. In
addition, although the Leiden Longevity Study described an
association between high 25-hydroxyvitamin D and the
degree of pigmented spots in an earlier publication (van
Drielen et al., 2015a), this association was not observed in
the Rotterdam Study. There is no clear reason for this differ-
ence, as different methodologies (image analysis vs.
photonumeric grading) show large similarities (Hamer et al.,
2015).
We did not find evidence of an association between higher
genetically determined 25-hydroxyvitamin D levels and
features of facial skin aging. Our findings suggest that the
observations in the previously published in vitro experiments
(Bollag et al., 1995; Gniadecki, 1996; Manggau et al., 2001)
might not have in vivo relevance. This could be because
most in vitro studies demonstrate beneficial effects of the
most potent vitamin D metabolite (1,25-hydroxyvitamin D)
at very high physiological levels (100 nmol/l) compared
with no vitamin D (Bollag et al., 1995; Gniadecki, 1996;
Manggau et al., 2001). In contrast, most participants in the
present study had a 25-hydroxyvitamin D concentration
between 40 and 140 nmol/l; hence, the biological effects in
this range will likely be lower. However, bioavailable levels
of 25-hydroxyvitamin D and 1,25 hydroxyvitamin D in skin
need to be ascertained to determine the relevance of the
in vitro studies to in vivo conditions.www.jidonline.org 2293
Table 3. Association between 25-hydroxyvitamin D genetic risk score and skin aging features
Rotterdam Study (N [ 3,831) Leiden Longevity Study (N[ 661) Meta-analysis
b (SE) P-value b (SE) P-value b (SE) P-value
Perceived age e0.017 (0.045) 0.69 0.046 (0.026) 0.08 0.030 (0.023) 0.18
Perceived age, adjusted1 e0.003 (0.034) 0.93 0.023 (0.018) 0.19 0.017 (0.016) 0.28
Degree of skin wrinkling e0.064 (0.048) 0.18 0.034 (0.035) 0.32 0.000 (0.028) 1.00
Degree of pigmented spots2 0.004 (0.051) 0.93 0.084 (0.038) 0.03 0.055 (0.030) 0.07
Effect estimates presented as the increase in the standardized outcomes per one unit increase in the genetic risk score.
Abbreviation: SE, standard error.
1Analyses additionally adjusted for the degree of facial skin wrinkling.
2Analysis based on 2,843 individuals from the Rotterdam Study. Analyses adjusted for age and sex. Effect estimates of the meta-analysis obtained using fixed-
effect models.
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2294There was no significant association between the genetic
score for pigmented spots and vitamin D levels. However,
there was a borderline significant association between a
single nucleotide polymorphism in the IRF4 gene and 25-
hydroxyvitamin D concentration, replicating a similar
finding in a different cohort (Saternus et al., 2015). This
finding warrants follow-up particularly because many of the
pigmented spot genes are also linked to melanin levels in
skin, which protects skin from UVB radiation effects, the key
determinant of vitamin D production in skin.
The observational associations between 25-hydroxyvitamin
D concentration and a higher perceived age and a higher
degree of skin wrinkling could be the result of residual con-
founding or reverse causality. However, single nucleotide
polymorphisms in the MC1R gene associate with a higher
perceived age, but were unrelated to 25-hydroxyvitamin D
concentration in our study population suggesting that reverse
causality is not at play here. We believe that the most likely
explanation for the association between 25-hydroxyvitamin D
concentration and features of skin aging is residual con-
founding, probably due to UVB radiation exposure.
The present study has a number of limitations. First, the
assessment of the degree of skin wrinkling and pigmented
spots was different in the Rotterdam Study and the Leiden
Longevity Study, which might have caused increased
disparity in the data. The differences in perceived age be-
tween the two cohorts (despite having a similar chronological
age) might originate from slight methodological differencesTable 4. Mendelian randomization analyses for pigmented
Rotterdam Study (N[ 2,843) Le
b (SE) P-value
IRF4 gene, rs12203592 0.017 (0.014) 0.20
MC1R gene, rs35063026 e0.007 (0.017) 0.67 e
ASIP gene, rs6059655 0.000 (0.015) 1.00
Pigmented spots GRS 0.079 (0.106) 0.45
Effect estimates presented as the increase in the standardized outcomes per on
Effect estimates of the meta-analysis obtained using fixed-effect models..
Abbreviations: ASIP, agouti signaling protein; GRS, genetic risk score; IRF4, in
error.
Journal of Investigative Dermatology (2017), Volume 137as well as differences in lifestyle factors and medical history.
However, we used the data on comparable scales (Z-scores)
and there is large agreement between digital and manual
assessment of skin wrinkling and pigmented spots (Hamer
et al., 2015). The present study populations only comprised
individuals from European ancestry, and our study findings
might therefore not necessarily be generalizable to pop-
ulations of different ancestry backgrounds. In addition,
regarding the observational associations found between 25-
hydroxyvitamin D, the available UV variables used might
not have captured cumulative sun exposure accurately.
However, this would not affect the Mendelian randomization
analyses. Furthermore, although we have validated the GRS
for 25-hydrxoyvitamin D against 25-hydroxyvitamin D levels
in our study populations, we cannot completely rule out that
the lack of evidence for an association between the GRS and
features of skin aging is the result of a lack of power for the
GRS to detect 25-hydroxyvitamin D effects in skin. Lastly, the
facial photographs of the Rotterdam Study and the Leiden
Longevity Study were taken at a later moment in time than
the blood drawing for 25-hydroxyvitamin D assessment,
which could have weakened any observational links.
In summary, we did not find evidence that the previously
described beneficial in vitro effects of vitamin D on cellular
processes are detectable at a population level. The observa-
tional associations in our study between 25-hydroxyvitamin D
and features of skin aging are, most likely, predominately due
to residual confounding.spots and 25-hydroxyvitamin D concentration
iden Longevity Study (N[ 661) Meta-analysis
b (SE) P-value b (SE) P-value
0.056 (0.023) 0.01 0.028 (0.012) 0.02
0.014 (0.023) 0.54 e0.009 (0.014) 0.49
0.020 (0.020) 0.30 0.007 (0.012) 0.55
0.306 (0.163) 0.06 0.146 (0.089) 0.10
e unit increase in the genetic risk score. Analyses adjusted for age and sex.
terferon regulatory factor 4; MC1R, melanocortin 1 receptor; SE, standard
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Study setting
The present study was conducted using data from the population-
based Rotterdam Study and the Leiden Longevity Study. The Rot-
terdam Study is an ongoing prospective population-based cohort
study following 14,926 inhabitants aged 45 years in Ommoord, a
suburb of Rotterdam in the Netherlands since 1990. Participants
were examined at baseline at the study center and invited every 4e5
years for follow-up visits at the study center. Details of the study
design and objectives have been described elsewhere (Hofman
et al., 2015). The Leiden Longevity Study recruited a total of 421
families containing long-lived Caucasian siblings (Westendorp et al.,
2009). Families were only included when at least two long-lived
siblings were still alive and met the age criteria upon study inclu-
sion (89 years for men; 91 years for women). Here, the study was
conducted in the offspring of the long-lived individuals with the
partners of the offspring as controls. A more detailed description of
the recruitment strategy of the study participants has been published
elsewhere (Schoenmaker et al., 2006).
Both studies were approved by local Medical Ethics Committees
and all included participants provided written informed consent.
Serum measurements
In the Rotterdam Study, fasted blood samples were collected be-
tween 1997 and 1999, 2000 and 2001, and 2006 and 2009, for each
participant only once. Serum 25-hydroxyvitamin D concentrations
were measured using electrochemiluminescence immunoassay
(COBAS; Roche Diagnostics, Mannheim, Germany).
In the Leiden Longevity Study, nonfasted blood samples were
collected between 2002 and 2006. Plasma 25-hydroxyvitamin D
levels were measured with monoclonal antibodies using a stan-
dardized protocol with electrochemiluminescence immunoassays
on a fully automated Cobas e411 analyzer (Roche Diagnostics,
Almere, the Netherlands). As part of the standard protocol, stan-
dardization was performed to make the measures comparable to
assays using polyclonal antibodies.
Skin aging features
In the Rotterdam Study, standardized high-resolution digital three-
dimensional (3D) facial photographs (Premier 3dMDface3-plus
UHD, Atlanta, GA) are being collected since 2010. Enface and
side 2D photographs were exported from the 3D images. The current
study included 3,831 participants of north-western European
ancestry, who have been photographed and examined at the
research center from September 2010 until June 2014. Perceived age
was assessed from front and side facial exported 2D images by on
average 27 assessors per image using a previously established (Gunn
et al., 2015) and validated (Gunn et al., 2008) method. Pigmented
spots and wrinkles were measured quantitatively from frontal 2D
images using image analysis algorithms (MATLAB 2013b) as previ-
ously described and validated (Hamer et al., 2015). Visual inspec-
tion of the image analyses measurements (Jacobs et al., 2015)
highlighted that the measurement mainly detected solar lentigines
and very few nevi. Individuals with freckles (n ¼ 23), facial contu-
sion (n ¼ 1), facial scars with hyperpigmentation (n ¼ 1), and
postinflammatory hyperpigmentation (n ¼ 1) were excluded.
In the Leiden Longevity Study, the method to determine a person’s
perceived age has been described and validated previously
(Christensen et al., 2009; Gunn et al., 2008, 2009). From all par-
ticipants, without make-up or hairstyling product, we took one facial
photograph from the front and one at 45. Photographs, with hairand clothing concealed, were assessed to determine the average
perceived age by 60 independent assessors. Skin wrinkling grade
was determined on a nine-point scale by visual assessment of front-
on, whole-face photographs (Griffiths, 1992). Pigmented spots were
graded by visual assessment of light, patchy, mottled hyperpigmen-
tation, actinic lentigines, seborrheic keratosis, and solar freckling
(Gunn et al., 2009); nevi were excluded from the grading. The grade
on a nine-point photographic scale was determined using quanti-
tative and qualitative criteria such as the area/density of pigmenta-
tion, color intensity, and uniformity of distribution (Griffiths et al.,
1992; Gunn et al., 2009).
Covariables
Chronological age was determined on the day the facial photographs
were taken. Weight and height were determined by research nurses
at the study center. Body mass index was calculated by dividing
weight (in kilograms) by height (in meters squared). Smoking status
was determined using a home questionnaire. Season was deter-
mined at the moment blood was drawn for measuring 25-
hydroxyvitamin D. For the digital measurements in the Rotterdam
Study, analyses were additionally adjusted for two technical vari-
ables. For both wrinkles and pigmented spots, flashlight variance
was taken into account: the within-person difference between skin
lightness in the images and that assessed by a spectrophotometer
(CM-600d; Konica-Minolta, Osaka, Japan) on the cheek. In addition
for wrinkles, a difference in resolution between two sets of the im-
ages was taken into account using a variable described as batch
(Hamer et al., 2015). In a random subpopulation of the Rotterdam
Study, six variables were available as proxy for UV exposure based
on interview data: tendency to develop sunburn (low vs. high),
history of working or being outdoors 4 hours daily during at least
25 years (yes vs. no), having wintered in a sunny country between
September and May for at least 1 month during the past 5 years (yes
vs. no), having lived in a sunny country for more than 1 year (yes vs.
no), sun protective behavior (i.e., wearing sunglasses and/or a
brimmed hat in the sun categorized into never/almost never vs.
often/almost always/always), and frequency of tanning bed visits
including facial solarium (fewer vs. more than 10 times in the past 5
years). Vitamin D from dietary intake (measured in mg/day) was
calculated using data collected by a food-frequency questionnaire
(Goldbohm et al., 1994). The Dutch Food Composition Table of
2006 and 2011 (RIVM, 2006/2011) was used to transform the data
into daily macronutrient intake and total energy intake (kcal/day).
Physical activity (measured in METhours/week) was assessed using
the LASA Physical Activity Questionnaire (Stel et al., 2004). Partic-
ipants were categorized as vitamin D supplement users if they used
vitamin D or multivitamin supplements at least once a week.
Genotyping
For the Rotterdam Study, DNA from whole blood was extracted and
genotyped following standard protocols (Hofman et al., 2015). In
brief, genotyping was carried out using the Infinium II HumanHap
550K Genotyping BeadChip version 3 (Illumina, San Diego, CA) for
the largest part of the cohort and Illumina Human 610 Quad Arrays
for the rest of the cohort. Genome-wide genotype data was imputed
using 1000 Genomes (GIANT Phase I version 3) as the reference
panel (1000 Genomes Project Consortium et al., 2012), using a two-
step procedure imputation algorithm implemented in the program
MACH-Minimac with default parameters (Howie et al., 2012). For
the Leiden Longevity Study, genotyping was conducted with the
Illumina Human 660W-Quad and OmniExpress BeadChipswww.jidonline.org 2295
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2296(Illumina). Individuals were excluded from further investigation if
they had a mismatch in sex or familial relatedness based on geno-
type and phenotype.
We extracted three genetic variants as instrumental variables for
25-hydroxyvitamin D: rs2282679 (GC), rs3829251 (NADSYN1), and
rs2060793 (CYP2R1) (Ahn et al., 2010), and extracted three genetic
variants as instrumental variables for pigmented spots: rs12203592
(IRF4), rs35063026 (MC1R), rs6059655 (ASIP) (Jacobs et al., 2015).
The MC1R gene has also been associated with perceived age (Liu
et al., 2016).
On the basis of the effect sizes observed in the genome-wide
association studies, we calculated a weighted GRS for the above-
mentioned determinants. GRS for 25-hydroxyvitamin D:
rs2282679-C*0.38 þ rs3829251-C*0.18 þ rs2060793-A*0.25 (Ahn
et al., 2010). GRS for facial pigmented spots: rs12203592-
T*0.097 þ rs35063026-T*0.080 þ rs6059655-A*0.059 (Jacobs
et al., 2015).
Statistical analyses
Characteristics of the study populations are presented as means (SD)
for normally distributed determinants, medians (interquartile range)
for non-normally distributed determinants and frequencies (per-
centages) for categorical determinants, separately for the Rotterdam
Study and Leiden Longevity Study.
As methodologies for determining the skin aging features differed
between the Rotterdam Study and the Leiden Longevity, study out-
comes were standardized to obtain a standard normal distribution.
Analyses were done separately for the two cohorts, and subsequently
meta-analyzed using fixed-effect meta-analysis, as part of the rmeta
package in R (http://www.R-project.org). For the analyses in the
Rotterdam Study, multiple imputation was performed, using the
Multiple Imputation by Chained Equations (MICE) package in R,
with an iteration of 20 (maximum missing data per variable was 6%).
We used linear regression analyses, adjusted for age, sex, body mass
index, current smoking, and season to obtain the observational effect
estimates for the association between 25-hydroxyvitamin D con-
centrations and the skin aging features. On the basis of the obser-
vational effect estimates in our total study population and
considering an a of 0.05, we calculated the statistical power for the
Mendelian randomization analysis on the skin aging features using a
publicly available power calculator (http://cnsgenomics.com/shiny/
mRnd/). Associations between 25-hydroxyvitamin D genotypes
and the GRS for 25-hydroxyvitamin D were adjusted for age and sex.
We also performed the Mendelian randomization analyses for the
genetic instruments for pigmented spots and perceived age (MC1R
only) with linear regression analyses, adjusted for age and sex.
All analyses for wrinkles and pigmented spots in the Rotterdam
Study were additionally adjusted for the two technical variables
mentioned above. Two-sided P-values below 0.05 were considered
statistically significant.
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